BDA advises Epolin Chemicals on sale to Chroma Color, an Arsenal Capital portfolio company

BDA Partners is pleased to announce that its client, Epolin Chemicals, has been sold to Chroma Color Corp, an Arsenal Capital portfolio company. 

Epolin, based in Newark, New Jersey, is a global leader in near-infrared absorbing dyes and thermoplastic compounds. Epolin serves customers developing groundbreaking products in sensors, security inks, light filters, touch-screens, night vision products and eyewear. Epolin will operate as an independent subsidiary of Chroma, and will continue to maintain and invest in its strong customer and supplier relationships.

BDA Partners was the exclusive financial advisor to Epolin, and to its shareholder Polymathes Capital, on the transaction.

Tom Bolger, CEO of Chroma, said, “This acquisition of Epolin will contribute significantly to Chroma Color’s leadership in the colorants and additives industry. We are excited to add Epolin’s cutting-edge NIR Dye technology to our expanding product portfolio and the members of the Epolin team to the Chroma family.” 

Greg Amato, CEO, Epolin Chemicals, said, “The many advantages Epolin customers will enjoy as a result of this transaction, include access to Chroma Color’s extensive product development, testing and validation capabilities, which are of immense value. Epolin’s customers can now be served by Chroma Color’s R&D efforts, to deliver new solutions for the markets that both Epolin and Chroma Color serve.” 

Euan Rellie, Senior Managing Director, BDA New York, said, “We’re proud to have worked for Epolin to help engineer this transaction, and to have secured the ideal partner for our friends at Arsenal and Chroma. Epolin is a unique company, a global leader in specialised colorants and dyes. BDA has a strong track record in chemicals. This transaction represents a good outcome for all parties.”